The role of PET scan in the preoperative management of oesophageal cancer

Refaely, 2002, Multimodality therapy for esophageal cancer, Surg Clin North Am, 82, 729, 10.1016/S0039-6109(02)00029-4 El Nakadi, 1993, Does esophagectomy cure a resectable esophageal cancer?, World J Surg, 17, 760, 10.1007/BF01659089 Chung, 1994, Surgical therapy for squamous-cell carcinoma of the oesophagus, Lancet, 343, 521, 10.1016/S0140-6736(94)91467-2 Roth, 1993, 717 Anderson, 1982, Autopsy findings in squamous-cell carcinoma of the esophagus, Cancer, 50, 1587, 10.1002/1097-0142(19821015)50:8<1587::AID-CNCR2820500820>3.0.CO;2-S Herskovic, 1992, Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus, N Engl J Med, 326, 1593, 10.1056/NEJM199206113262403 Saunders, 1997, Esophageal cancer, Radiol Clin North Am, 35, 281, 10.1016/S0033-8389(22)00708-4 Barbier, 1988, Quality of life and patterns of recurrence following transhiatal esophagectomy for cancer: results of a prospective follow-up in 50 patients, World J Surg, 12, 270, 10.1007/BF01658073 Ziegler, 1991, Evaluation of endosonography in TN staging of esophageal cancer, Gut, 32, 16, 10.1136/gut.32.1.16 Dittler, 1993, Role of endoscopic ultrasonography in esophageal carcinoma, Endoscopy, 25, 156, 10.1055/s-2007-1010275 O'Brien, 1995, A prospective comparison of laparoscopy and imaging in the staging of esophagogastric cancer before surgery, Am J Gastroenterol, 90, 2191 Yasuda, 1995, Application of whole body positron emission tomography in the imaging of esophageal cancer: report of a case, Surg Today, 25, 261, 10.1007/BF00311538 Luketich, 1996, A comparaison of endoscopic ultrasound and minimally invasive surgical staging in esophageal cancer, Am J Gastroenterol, 91, 1892 Luketich, 1997, The role of positron emission tomography in staging esophageal cancer, Ann Thorac Surg, 64, 765, 10.1016/S0003-4975(97)00624-3 Meltzer, 2000, Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography, Clin Nucl Med, 25, 882, 10.1097/00003072-200011000-00005 Flanagan, 1997, Staging of esophageal cancer with F-18-fluorodeoxyglucose positron emission tomography, Am J Roentgenol, 168, 417, 10.2214/ajr.168.2.9016218 Block, 1997, Improvement in staging of esophageal cancer with the addition of positron emission tomography, Ann Thorac Surg, 64, 770, 10.1016/S0003-4975(97)00619-X Fukunaga, 1998, Evaluation of esophageal cancers using fluorine-18-fluorodeoxyglucose Pet, J Nucl Med, 39, 1002 Kole, 1998, Positron emission tomography for staging of esophageal and gastroesophageal malignancy, Br J Cancer, 78, 521, 10.1038/bjc.1998.526 Rankin, 1998, Computed tomography and positron emission tomography in the pre-operative staging of esophageal carcinoma, Clin Radiol, 53, 659, 10.1016/S0009-9260(98)80292-4 Choi, 2000, Improved detection of individual nodal involvment in squamous cell carcinoma of the esophagus by FDG PET, J Nucl Med, 41, 808 Mason, 1997, PET scanning for assessing resectability of oesophageal cancer-preliminary results, Gut, 40, 148 McAteer, 1999, Evaluation of 18F-FDG positron emission tomography in gastric and esophageal carcinoma, Br J Radiol, 72, 525, 10.1259/bjr.72.858.10560332 Lerut, 2000, Histopathologic validation of lymph node staging with FDG–PET scan in cancer of the esophagus and gastroesophageal junction: a prospective study based on primary surgery with extensive lymphadenectomy, Ann Surg, 232, 743, 10.1097/00000658-200012000-00003 Räsänen, 2003, Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction, Ann Surg Oncol, 10, 954, 10.1245/ASO.2003.12.002 Sobin, 1997 Beck, 1986, Likelihood ratios. Another enhancement of sensitivity and specificity, Arch Pathol Lab Med, 110, 685 Chandarwarkar, 1996, Comparative analysis of imaging modalities in the preoperative assessment of nodal metastasis in esophageal cancer, J Surg Oncol, 561, 214, 10.1002/(SICI)1096-9098(199603)61:3<214::AID-JSO10>3.0.CO;2-7 Kato, 2002, Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma, Cancer, 94, 921, 10.1002/cncr.10330 Kneist, 2003, Positron emission tomography for staging esophageal cancer: does it lead to a different therapeutic approach?, World J Surg, 27, 1105, 10.1007/s00268-003-6921-z Couper, 1998, Detection of response to chemotherapy using positron emission tomography in patients with esophageal and gastric cancer, Br J Surg, 85, 1403, 10.1046/j.1365-2168.1998.00963.x Brücher Björn, 2001, Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography, Ann Surg, 233, 300, 10.1097/00000658-200103000-00002 Kato, 2002, Usefulness of positron emission tomography for assessing the response of neoajuvant chemoradiotherapy in patients with esophageal cancer, Am J Surg, 184, 279, 10.1016/S0002-9610(02)00932-7 Flamen, 2000, The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer, J Thorac Cardiovasc Surg, 120, 1085, 10.1067/mtc.2000.110464 Strauss, 1996, Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients, Eur J Nucl Med, 23, 1409, 10.1007/BF01367602